Histogenics Corporation to Present at 18th Annual BIO CEO & Investor Conference
January 26, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation to Present at Biotech Showcase 2016
January 06, 2016 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria
December 21, 2015 08:15 ET
|
Histogenics Corporation
WALTHAM, Mass., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Announces Third Quarter 2015 Financial and Operating Results
November 12, 2015 06:30 ET
|
Histogenics Corporation
- Completion of Enrollment of NeoCart® Phase 3 Trial Now Expected in Second Quarter of 2017 - - Company to Host Conference Call and Webcast Today at 8:30 a.m. EST - WALTHAM, Mass., Nov. 12, 2015 ...
Histogenics Corporation to Announce Third Quarter 2015 Financial Results on November 12, 2015
October 29, 2015 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal...
Histogenics Corporation to Participate in Upcoming Scientific and Investor Conferences
October 01, 2015 09:23 ET
|
Histogenics Corporation
WALTHAM, Mass., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation and Collagen Solutions plc Establish Supply Agreement
WALTHAM, Mass., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal...
Histogenics Corporation Announces Second Quarter 2015 Financial and Operating Results
August 12, 2015 06:30 ET
|
Histogenics Corporation
- Continued Progress on NeoCart® Phase 3 Trial and 2015 Business Objectives -
- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT -
WALTHAM, Mass., Aug. 12, 2015 (GLOBE...
Histogenics Corporation to Present at the Canaccord Genuity Growth Conference
August 04, 2015 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Announces Appointment of Stephen Kennedy to Chief Technology Officer
July 30, 2015 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...